Vaccine Scheduler
Lithuania: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Months | Years | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 12 | 15 | 16 | 18 | 23 | 2 | 6-7 | 8 | 11 | 15-16 | 18 | ||||
| Coronavirus disease (COVID-19) | COVID-191 | |||||||||||||||||||
| tuberculosis | BCG | |||||||||||||||||||
| rotavirus infection | ROTA | ROTA | ROTA | |||||||||||||||||
| diphtheria | D | D | D | D | D | d2 | ||||||||||||||
| tetanus | TT | TT | TT | TT | TT | TT2 | ||||||||||||||
| pertussis | acP | acP | acP | acP | acP | acp | acp3 | |||||||||||||
| poliomyelitis | IPV | IPV | IPV | IPV | IPV | |||||||||||||||
| Haemophilus influenzae type b infection | Hib | Hib | Hib | Hib | ||||||||||||||||
| hepatitis B | HepB | HepB | HepB | |||||||||||||||||
| pneumococcal disease | PCV15 | PCV15 | PCV154 | PCV205 | ||||||||||||||||
| meningococcal disease | MenB | MenB | MenB4 | |||||||||||||||||
| measles | MEAS | MEAS | ||||||||||||||||||
| mumps | MUMPS | MUMPS | ||||||||||||||||||
| rubella | RUBE | RUBE | ||||||||||||||||||
| human papillomavirus infection | HPV9 (F/M)6 | |||||||||||||||||||
| influenza | IIV37 | IIV37 | IIV37 | |||||||||||||||||
Version:
Footnotes:
- Vaccine is recommended for persons 65 years of age and older and for risk groups with underlying conditions from 6 months of age. More information available at: https://koronastop.lrv.lt/lt/vakcina
- Subsequent booster doses every 5-10 years
- Vaccination during pregnancy
- Can be administered concomitantly with MMR
- Vaccination is recommended for unvaccinated children and adults younger than 65 years of age with underlying conditions.
- Girls and boys are vaccinated with a two-dose schedule (6 months a part).
- Vaccination is recommended for children 2 to 7 years old, for persons 65 years of age and older and risk groups persons (with underlying conditions, pregnant women, health care workers, medical students).
More information available at:
https://sam.lrv.lt/lt/veiklos-sritys/visuomenes-sveikatos-prieziura/uzkreciamuju-ligu-valdymas/skiepai https://www.e-tar.lt/portal/lt/legalAct/64b65e3023ca11e9bf1ef395f41d6fbc/asr https://www.e-tar.lt/portal/lt/legalAct/333a8c10ab9211e88f64a5ecc703f89b https://sam.lrv.lt/uploads/sam/documents/files/Veiklos_sritys/visuomenes-sveikatos-prieziura/skiepai/A5-Suaugusiuju-skiepijimo-Lietuvoje-rekomendacijos_2022%20r.pdf
--------------------------------------------------------------------------------------------------
MAJOR HISTORICAL CHANGES
1964: Measles vaccination introduced in the national childhood vaccination schedule.
1981: Mumps vaccination introduced in the national childhood vaccination schedule.
1992: Rubella vaccination introduced in the national childhood vaccination schedule.
1996: One dose of MMR vaccination recommended at 15 months while measles and mumps vaccination recommended at 12 years.
1998: Two dose MMR regimen recommended at 15 months (MMR1) and 12 years (MMR2) of age.
2002: Age of MMR2 vaccination lowered to 6-7 years of age
2014: MMR2 catch-up programme introduced for children 12 years of age and HepB for children at 12 years of age not vaccinated.
2014: Pneumococcal disease vaccination introduced in the national childhood immunisation schedule
2015: Tetanus, diphtheria, pertussis vaccination introduced in the national childhood immunisation schedule for 15-16 year-old adolescents
2016: Human papilloma virus vaccination introduced in the national childhood immunisation schedule
2018: Meningococcal disease vaccination introduced in the national childhood immunisation schedule
2018: Rotavirus disease vaccination introduced in the national childhood immunisation schedule
2023: HPV 9 valent as gender neutral vaccination (1 Feb 2023)
The following are vaccinations recommended to all above 18 years: diphtheria/tetanus (booster dose every 5-10 years), influenza (every year), pneumococcal disease, tick-borne encephalitis, varicella, hepatitis A, hepatitis B, human papillomavirus infection and meningococcal disease.
for more information on the adult programme please refer to https://sam.lrv.lt/uploads/sam/documents/files/Veiklos_sritys/visuomenes-sveikatos-prieziura/skiepai/A5-Suaugusiuju-skiepijimo-Lietuvoje-rekomendacijos_2022%20r.pdf
____________________________________________________________
Date of last update: 4 February 2026
--------------------------------------------------------------------------------------------------